Pregestational diabetes.
The prevalence of preexisting diabetes in pregnancy is increasing largely because of an increase in type 2 diabetes. Outcomes of diabetic pregnancies for mother and newborn have improved greatly in recent decades from advances in understanding the disease process, improved education, and new treatment modalities delivered in a team approach. Nausea and vomiting from pregnancy and pregnancy-associated insulin resistance can make glycemic control a challenge. Care of women with preexisting diabetes demands careful monitoring in the preconception, prenatal, and peripartum periods.
Pridjian
Gabriella
G
Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, SL11, Tulane University Medical School, 1430 Tulane Avenue, New Orleans, LA 70112, USA. Pridjian@Tulane.edu
D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000145:classification / Q000628:therapy; D004032:Diet; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D005865:Gestational Age; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D016742:Preconception Care; D011247:Pregnancy / Q000378:metabolism; D011248:Pregnancy Complications; D011254:Pregnancy in Diabetics / Q000145:classification / Q000628:therapy; D012307:Risk Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin